Management of Pediatric Streptococcal Pharyngitis
Diagnostic Testing
Confirm Group A Streptococcus (GAS) infection with a rapid antigen detection test (RADT) before prescribing antibiotics; clinical features alone cannot reliably distinguish bacterial from viral pharyngitis. 1, 2
- Perform RADT when the child presents with sudden-onset sore throat, fever, tonsillar exudates, tender anterior cervical lymphadenopathy, and absence of viral features (cough, rhinorrhea, hoarseness, conjunctivitis). 1, 3
- A positive RADT is diagnostic (specificity ≥95%) and does not require backup throat culture. 1, 2
- A negative RADT in children must be followed by throat culture because RADT sensitivity is only 80–90%, missing 10–20% of true infections. 1, 3, 2
- Do not test children younger than 3 years unless an older sibling has confirmed GAS, as streptococcal pharyngitis and acute rheumatic fever are rare in this age group. 1, 3
First-Line Antibiotic Therapy
Prescribe oral amoxicillin 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for a mandatory 10-day course. 1, 2
- Amoxicillin is preferred over penicillin V in children because of better palatability, liquid suspension availability, and improved adherence with once- or twice-daily dosing. 1
- No documented penicillin resistance exists worldwide among Group A Streptococcus, ensuring reliable bacterial eradication. 1
- Alternative: Penicillin V 250 mg 2–3 times daily for children <27 kg; 500 mg 2–3 times daily for children ≥27 kg, for 10 days. 1, 2
- Intramuscular benzathine penicillin G (600,000 units for <27 kg; 1.2 million units for ≥27 kg) as a single dose if oral adherence is uncertain. 1, 2
Treatment Duration
A complete 10-day antibiotic course is essential to achieve maximal pharyngeal eradication and prevent acute rheumatic fever; shortening the course by even 2–3 days markedly increases treatment failure and rheumatic fever risk. 1, 2
- The primary goal is prevention of acute rheumatic fever, not merely symptom relief; this requires complete bacterial eradication. 1, 3
- Therapy initiated within 9 days of symptom onset still effectively prevents acute rheumatic fever. 1, 3
- Symptoms typically resolve within 3–4 days, but the full 10-day course must be completed regardless of clinical improvement. 1
Management of Penicillin-Allergic Patients
Non-Immediate (Delayed) Penicillin Allergy
Prescribe a first-generation cephalosporin: cephalexin 20 mg/kg twice daily (maximum 500 mg per dose) for 10 days. 1, 2
- Cross-reactivity risk with delayed penicillin reactions is only 0.1%, making cephalosporins safe and preferred. 1
Immediate/Anaphylactic Penicillin Allergy
Avoid all β-lactam antibiotics (including cephalosporins) due to up to 10% cross-reactivity risk; prescribe clindamycin 7 mg/kg three times daily (maximum 300 mg per dose) for 10 days. 1, 2
- Clindamycin resistance among U.S. GAS isolates is approximately 1%, and it demonstrates superior eradication even in chronic carriers. 1
- Alternative macrolides (less preferred due to 5–8% resistance):
Symptomatic Management
Offer acetaminophen or ibuprofen for moderate-to-severe sore throat, fever, or systemic discomfort. 1, 2
- Avoid aspirin in children due to the risk of Reye syndrome. 1, 2
- Corticosteroids are not recommended as adjunctive therapy. 1
Return to School Criteria
Children may return to school or daycare after completing at least 24 hours of antibiotic therapy. 1
- Approximately 36% may still have positive throat cultures after the first dose, so the 24-hour threshold ensures adequate bacterial suppression. 1
Common Pitfalls to Avoid
- Do not prescribe antibiotics without confirming GAS via RADT or culture; most pharyngitis cases (70–80%) are viral. 1, 3
- Do not shorten the antibiotic course below 10 days (except azithromycin's 5-day regimen), as this dramatically increases treatment failure and rheumatic fever risk. 1, 2
- Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions due to the ~10% cross-reactivity risk. 1
- Do not test or treat asymptomatic household contacts; up to one-third may be asymptomatic carriers, and prophylactic treatment does not reduce subsequent infection rates. 1, 3
- Do not order routine post-treatment throat cultures for asymptomatic children who completed therapy; positive results often reflect carrier status rather than treatment failure. 1, 3
Management of Treatment Failure
If symptoms persist after a fully adhered 10-day course, switch to clindamycin 7 mg/kg three times daily for 10 days to achieve higher eradication rates, especially in chronic carriers. 1
- Consider whether the child is a chronic GAS carrier experiencing superimposed viral infections rather than true recurrent streptococcal infections. 1, 3
- Chronic carriers generally do not require treatment unless special circumstances exist (e.g., family history of rheumatic fever, community outbreak). 1